Peptide-based ligand antagonists block a Vibrio cholerae adhesin

Area of Science:

• Microbiology
• Structural Biology
• Drug Discovery

Background:

• Vibrio cholerae causes cholera using surface proteins like the RTX adhesin FrhA for host colonization.
• Blocking bacterial adhesion is a key strategy to combat infections without driving drug resistance.
• FrhA's peptide-binding domain (PBD) is crucial for hemagglutination, cell binding, and biofilm formation.

Purpose of the Study:

• To elucidate the molecular basis of peptide recognition by the FrhA-PBD.
• To develop novel, high-affinity peptide inhibitors of V. cholerae adhesion.
• To advance anti-adhesion strategies for treating cholera and related infections.

Main Methods:

• Structure-guided design of peptide ligands targeting the FrhA-PBD.
• Identification and characterization of D-amino acid-containing tripeptide motifs.
• Affinity assessment using nanomolar concentration measurements.

Main Results:

• A minimal D-amino acid tripeptide motif with significantly higher affinity for FrhA-PBD was identified.
• The new peptides exhibit nanomolar affinity, outperforming previous high micromolar ligands.
• Predicted metabolic stability suggests potential for therapeutic applications.

Conclusions:

• The study provides a molecular understanding of FrhA-peptide interactions.
• Developed D-amino acid peptides represent a new class of anti-adhesion therapeutics.
• Findings offer a structural blueprint for next-generation anti-adhesion drugs against V. cholerae infections.